試す 金 - 無料
Odisha's pharma pitch
Express Pharma
|January 2026
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
-
The recently held Odisha Pharma Summit 2025, the state's first dedicated summit focused on pharmaceuticals, medical devices, and life sciences manufacturing, is by all accounts a success. (https://www.expresspharma.in/odisha-pharma-summit-2025-positions-odisha-as-eastern-indias-emerging-life-sciences-hub-odisha-cm/)
The December 16 summit reportedly attracted strong investor response, with a total of 69 Memoranda of Understanding (MoUs) signed across pharmaceuticals, medical technologies, and industrial infrastructure. These MoUs represent an investment commitment of Rs 7,043 crore, with an estimated employment generation potential of 44,646 jobs.
Pharmaceuticals bagged the lion's share (32 MoUs with proposed investments of Rs 2,681 crore, generating over 6,528 employment opportunities) followed by Medical Technology & Devices (12 MoUs, Rs 582 crore in committed investments, to create over 1,878 jobs). An MoU was also signed to set up an industrial park, with an investment of Rs 3,000 crore, expected to generate nearly 30,000 jobs.
The Odisha government's pharma foray is part of the government's overall Viksit Bharat @2047 vision, and specifically to boost investment and development of Eastern India under the Purvodaya (look east) policy push.
The state has charted its own policy, Samruddha Odisha 2036, for becoming a developed, future-ready state by 2036, Odisha's centenary year of statehood.
Summing up the intent, Hon'ble Chief Minister Shri Mohan Charan Majhi while addressing the Odisha Pharma Summit 2025 on December 16, 2025 said, “Odisha will be a leading destination for pharmaceutical and medical-device investments – the most competitive hub for innovation and jobs. Yahi samay hai.”
But will Odisha catch up with more established pharma/medtech hubs in the country? After all, what does the “new kid on the block” offer to attract investments?
PLI plus policy
このストーリーは、Express Pharma の January 2026 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Express Pharma からのその他のストーリー
Express Pharma
Future opportunities in biologics and biosimilars will demand significant investment
Semaglutide's patent expiry in India in March 2026 has become the immediate trigger for the next wave of pharmaceutical development activity, but the larger opportunity goes well beyond semaglutide itself.
1 mins
April 2026
Express Pharma
Gandhi Automations elevates loading bay efficiency with advanced dock leveler solutions
Engineered systems from Gandhi Automations Pvt Ltd enhance safety, durability and seamless material flow
2 mins
April 2026
Express Pharma
Redefining humidity control in pharma manufacturing
Bry-Air systems reflect shift towards material-based humidity control in pharma manufacturing
2 mins
April 2026
Express Pharma
2026 amendments to NDCT Rules: Foreword to India's biosimilars story or a step too short?
Kosturi Ghosh, Partner, and Ajeya B G, Sr Associate, in the Corporate practice at Trilegal, assess India's 2026 NDCT amendments as a timely push for biosimilars, but not enough on their own. The article highlights that stronger policy clarity and ecosystem support will be critical to truly unlock growth.
4 mins
April 2026
Express Pharma
Optima advances digital twins to boost efficiency in pharmaceutical turnkey machines
Virtual testing, training and simulation tools enhance performance in complex manufacturing environments
7 mins
April 2026
Express Pharma
Complete environmental monitoring solution – testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
3 mins
April 2026
Express Pharma
Flexotherm heating tapes & cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
April 2026
Express Pharma
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover other critical drug categories in phases, all segments of the pharma value chain need to tighten their systems, analyses Viveka Roychowdhury
15 mins
April 2026
Express Pharma
This is only the beginning of a much larger global patent-cliff cycle
As the patent expiry of semaglutide is almost there in India, several Indian pharma firms are preparing to introduce generic versions, highlighting the sector's agility in responding to high-value loss-of-exclusivity opportunities.
1 min
April 2026
Express Pharma
Leading people in the age of Al
As Al reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and work, finds Lakshmipriya Nair
8 mins
April 2026
Listen
Translate
Change font size
